Spineguard (XPAR:ALSGD) ROE % Adjusted to Book Value: -24.30% (As of Dec. 2025)


What is Spineguard ROE % Adjusted to Book Value?

Spineguard XPAR:ALSGD -0.83% ROE % Adjusted to Book Value is -24.30% as of Dec. 2025. The stock has 4 warning signs investors should review.

Spineguard's ROE % for the quarter that ended in Dec. 2025 was -40.34%. Spineguard's PB Ratio for the quarter that ended in Dec. 2025 was 1.66. Spineguard's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was -24.30%.

Spineguard ROE % Adjusted to Book Value Related Terms

Spineguard ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Spineguard's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Spineguard ROE % Adjusted to Book Value Chart

Spineguard Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -10.28 -12.52 -47.69 -19.63 -26.57

Spineguard Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -45.05 -29.93 -22.64 -32.66 -24.30

XPAR:ALSGD vs ABT, SYK, MDT: ROE % Adjusted to Book Value Comparison

For the Medical Devices subindustry, Spineguard's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Spineguard ROE % Adjusted to Book Value vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Spineguard's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Spineguard's ROE % Adjusted to Book Value falls into.


Spineguard ROE % Adjusted to Book Value Calculation

Spineguard's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-44.11% / 1.66
=-26.57%

Spineguard's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-40.34% / 1.66
=-24.30%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -24.30% mean?
Spineguard (XPAR:ALSGD) has a ROE % Adjusted to Book Value of -24.30% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Spineguard and its competitors.
Is Spineguard's ROE % Adjusted to Book Value too high?
Spineguard's current ROE % Adjusted to Book Value is -24.30%.
How does Spineguard's ROE % Adjusted to Book Value compare to ABT and SYK?
Spineguard's ROE % Adjusted to Book Value of -24.30% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Devices & Instruments company?
A good ROE % Adjusted to Book Value depends on the Medical Devices & Instruments industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Spineguard and its competitors. Spineguard's current ROE % Adjusted to Book Value is -24.30%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spineguard stock overvalued right now?
Based on GuruFocus' analysis, Spineguard (XPAR:ALSGD) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.10, compared to a current price of €0.08 — trading 16.5% below its estimated fair value. The current ROE % Adjusted to Book Value is -24.30%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Spineguard (XPAR:ALSGD), the current ROE % Adjusted to Book Value is -24.30% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Spineguard Business Description

Other Exchanges 6W5:Germany
Address 10 Cours Louis Lumiere, Vincennes, FRA, 94300
Spineguard is engaged in the design and production of medical instruments used for spinal surgeries. It is deploying its proprietary radiation-free real time sensing technology DSG (Dynamic Surgical Guidance) to secure and streamline the placement of implants in the skeleton. It designs, develops and markets medical devices embedding its technology. The group is developing DSG digital technology for real-time surgical guidance without X-rays to improve the safety and simplify the placement of bone implants, pedicle screws, and smart drills. SpineGuard is extending the applications of its DSG technology to anterior scoliosis treatment, sacroiliac joint fusion, and dental implantology.